These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8396951)

  • 1. DNA flow cytometric analysis in patients with operable non-small cell lung carcinoma.
    Granone P; Cardillo G; Rumi E; D'Ugo D; Rumi C; Ciletti S; Margaritora S; Terribile D; Picciocchi A
    Eur J Cardiothorac Surg; 1993; 7(7):351-5. PubMed ID: 8396951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer.
    Isobe H; Miyamoto H; Shimizu T; Haneda H; Hashimoto M; Inoue K; Mizuno S; Kawakami Y
    Cancer; 1990 Mar; 65(6):1391-5. PubMed ID: 2155055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Flow cytometric analysis of the DNA content of resected non-small cell lung cancer with reference to long-term follow-up].
    Nagai S; Chiba W; Ikeda S; Matsumoto H; Fujimoto T; Ishida H; Wazawa H; Hanawa T; Yamashita N; Yasuda Y; Matsubara Y; Hatakenaka R; Funatsu T
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():130-4. PubMed ID: 8678555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric analysis of the DNA content of non-small cell lung cancer. Ploidy as a significant prognostic indicator in squamous cell carcinoma of the lung.
    Sahin AA; Ro JY; el-Naggar AK; Lee JS; Ayala AG; Teague K; Hong WK
    Cancer; 1990 Feb; 65(3):530-7. PubMed ID: 2153432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of flow cytometric DNA analysis in non-small-cell lung cancer: rationale of sequential processing of frozen and paraffin-embedded tissue.
    Mugüerza JM; Díez M; Torres AJ; López-Asenjo JA; Picardo AL; Gómez A; Hernando F; Cayón R; Granell J; Balibrea JL
    World J Surg; 1997; 21(3):323-9. PubMed ID: 9015179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of the surgical treatment of patients with non-small cell lung cancer (NSCLC)--relation to DNA ploidy.
    Gawrychowski J; Lackowska B; Gabriel A
    Eur J Cardiothorac Surg; 2003 Jun; 23(6):870-7; discussion 877. PubMed ID: 12829060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric analysis of the DNA content of adenocarcinoma of the lung, especially for patients with stage 1 disease with long term follow-up.
    Tanaka I; Masuda R; Furuhata Y; Inoue M; Fujiwara M; Takemura T
    Cancer; 1995 May; 75(10):2461-5. PubMed ID: 7736389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution of flow cytometry in the prognostic evaluation of non-small-cell lung cancers. Review of the literature].
    Jeanfaivre T; Chassevent A; Larra F; Tuchais E
    Bull Cancer; 1994 Jul; 81(7):605-9. PubMed ID: 7742603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.
    Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Di Carlo L; Semeraro A; Daddi G; Darwish S; Stocchi L; Tofanetti FR; Bellezza G; Sidoni A; Tognellini R; Crinò L; Tonato M
    Tumori; 2008; 94(3):398-405. PubMed ID: 18705409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior.
    Volm M; Mattern J; Sonka J; Vogt-Schaden M; Wayss K
    Cytometry; 1985 Jul; 6(4):348-56. PubMed ID: 2990835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.
    Miyamoto H; Harada M; Isobe H; Akita HD; Haneda H; Yamaguchi E; Kuzumaki N; Kawakami Y
    Cancer Res; 1991 Dec; 51(23 Pt 1):6346-50. PubMed ID: 1657384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA content in correlation with postsurgical stage in non-small cell lung cancer.
    Carp NZ; Ellison DD; Brophy PF; Watts P; Chang MC; Keller SM
    Ann Thorac Surg; 1992 Apr; 53(4):680-3. PubMed ID: 1313224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of tumor proliferative fraction and DNA content in stage I non-small cell lung cancer.
    Filderman AE; Silvestri GA; Gatsonis C; Luthringer DJ; Honig J; Flynn SD
    Am Rev Respir Dis; 1992 Sep; 146(3):707-10. PubMed ID: 1325749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung.
    Cibas ES; Melamed MR; Zaman MB; Kimmel M
    Cancer; 1989 Apr; 63(8):1552-6. PubMed ID: 2924263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Flow cytometric analysis of DNA content in lung cancer].
    Liu GX
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Oct; 15(5):290-2, 320. PubMed ID: 1339110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of the bronchoscopic DNA content analysis of non-small-cell lung carcinoma.
    Haneda H; Miyamoto H; Isobe H; Abe S; Akita H; Ishikuro A; Kawakami Y; Okayasu K; Endo T; Inoue K
    J Surg Oncol; 1992 Mar; 49(3):182-8. PubMed ID: 1312655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of flow cytometry in squamous cell bronchogenic cancer. A retrospective study of 61 cases].
    Jeanfaivre T; Chassevent A; Geslin J; Larra F; Tuchais E
    Bull Cancer; 1997 Jun; 84(6):597-602. PubMed ID: 9295862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Demonstration of independent cellular prognostic factors in squamous cell carcinoma of the lung].
    Volm M; Kayser K; Mattern J
    Strahlenther Onkol; 1989 Aug; 165(8):587-92. PubMed ID: 2772815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological characterization of central and peripheral primary non small cell lung cancers (NSCLC).
    Malara NM; Sgambato A; Granone P; Flamini G; Margaritora S; Boninsegna A; Cesario A; Galetta D; Yang Q; Cittadini A
    Anticancer Res; 1999; 19(3B):2249-52. PubMed ID: 10472338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers.
    Simony J; Pujol JL; Radal M; Ursule E; Michel FB; Pujol H
    Cancer Res; 1990 Jul; 50(14):4382-7. PubMed ID: 2163748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.